Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network.
advanced stage
low-grade serous ovarian cancer
neoadjuvant chemotherapy
surgery
survival
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
09 May 2022
09 May 2022
Historique:
received:
19
03
2022
revised:
26
04
2022
accepted:
28
04
2022
entrez:
14
5
2022
pubmed:
15
5
2022
medline:
15
5
2022
Statut:
epublish
Résumé
The surgical specificities of advanced low-grade serous ovarian carcinoma (LGSOC) have been little investigated. Our objective was to describe surgical procedures/complications in primary (PDS) compared to interval debulking surgery (neoadjuvant chemotherapy and interval debulking surgery, NACT-IDS) and to assess the survival (progression-free (PFS) and overall survival (OS)) in patients with advanced LGSOC. We retrospectively analyzed advanced LGSOC from a nationwide registry (January 2000 to July 2017). A total of 127 patients were included (48% PDS and 35% NACT-IDS). Peritoneal carcinomatosis was more severe (
Identifiants
pubmed: 35565475
pii: cancers14092345
doi: 10.3390/cancers14092345
pmc: PMC9105599
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Surg Pathol. 2004 Apr;28(4):496-504
pubmed: 15087669
Am J Obstet Gynecol. 2007 Dec;197(6):676.e1-7
pubmed: 18060979
Gynecol Oncol. 2013 Sep;130(3):660-6
pubmed: 23707670
Am J Surg Pathol. 2010 Mar;34(3):433-43
pubmed: 20154587
Obstet Gynecol. 2006 Aug;108(2):361-8
pubmed: 16880307
PLoS One. 2012;7(7):e39415
pubmed: 22844394
J Clin Med. 2021 Dec 17;10(24):
pubmed: 34945222
Am J Obstet Gynecol. 2008 Apr;198(4):459.e1-8; discussion 459.e8-9
pubmed: 18395040
Lancet Oncol. 2011 Mar;12(3):214
pubmed: 21376285
J Clin Oncol. 2017 Apr 1;35(10):1103-1111
pubmed: 28221866
J Chir (Paris). 2004 Sep;141(5):277-84
pubmed: 15494657
Gynecol Oncol. 2008 Mar;108(3):510-4
pubmed: 18155273
J Clin Oncol. 2016 Oct 1;34(28):3460-73
pubmed: 27502591
Surg Oncol. 2016 Sep;25(3):326-31
pubmed: 27566040
Ann Oncol. 2017 Jun 01;28(6):1274-1279
pubmed: 28398524
Cancer Treat Rev. 2015 Feb;41(2):136-43
pubmed: 25573350
Gynecol Oncol. 2016 Mar;140(3):457-62
pubmed: 26807488
J Clin Oncol. 2015 Aug 20;33(24):2675-82
pubmed: 26195696
Ann Surg. 1995 Jan;221(1):29-42
pubmed: 7826158
Obstet Gynecol. 2013 Aug;122(2 Pt 1):225-232
pubmed: 23969788
Gynecol Oncol. 2013 Sep;130(3):493-8
pubmed: 23747291
Cancer. 2009 Mar 15;115(6):1234-44
pubmed: 19189349
Cancer. 2013 Feb 1;119(3):548-554
pubmed: 22930283
Lancet Oncol. 2018 Dec;19(12):1558-1560
pubmed: 30413382